A Phase 2b Multicenter Dose-Ranging Study Evaluating the Safety and Efficacy of a Long-acting Intravitreal Sunitinib Malate Depot Formulation (GB-102) Compared to Intravitreal Aflibercept in Subjects with Neovascular (Wet) Age-related Macular Degeneratio

  • El-Annan, Jaafar (PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date8/21/198/20/23

Funding

  • Syneos Health, LLC: $9,625.00